DNA Methylation and Mutation

Abstract

Single‐gene and genome sequencing studies have identified base substitution mutations as a causative mechanism in human genetic diseases and cancer. These mutations do not occur randomly but are often enriched at specific DNA (deoxyribonucleic acid) sequences. The genome of most human cells contains about 50 million 5‐methylcytosine bases, the majority of them occurring at the CpG dinucleotide sequence. Methylated CpG dinucleotides are the targets of many of the mutations, mostly transition mutations (C→T or G→A), found in genetic disorders and in malignant tumours. The mechanisms that increase mutations at CpG sites include spontaneous deamination of 5‐methylcytosine and preferential interaction of such sequences with physical or chemical carcinogens. As a consequence of enhanced mutagenesis at methylated CpGs, the CpG frequency in mammalian genomes has been strongly depleted over evolutionary time.

Key Concepts

  • Methylated CpG sequences are preferentially mutated.
  • Deamination of 5‐methylcytosine leads to transition mutations at CpGs.
  • Exogenous carcinogens target methylated CpGs.
  • CpG mutations are frequent in genetic diseases and cancer.
  • DNA repair may be affected by methylation of CpG sequences.

Keywords: DNA methylation; mutation; CpG sequence; 5‐methylcytosine; DNA damage

Figure 1. Two mechanisms that operate at methylated CpG sequences to produce mutational hot spots. Deamination of 5‐methylcytosine can lead to C to T transition mutations after DNA (deoxyribonucleic acid) replication. Preferential modification of guanines at methylated CpG sequences (indicated by x) can lead to G to T transversions after DNA replication. A double‐stranded methylated CpG sequence is shown.
close

References

Alexandrov LB, Nik‐Zainal S, Wedge DC, Campbell PJ, et al. (2013a) Deciphering signatures of mutational processes operative in human cancer. Cell Reports 3: 246–259.

Alexandrov LB, Nik‐Zainal S, Wedge DC, et al. (2013b) Signatures of mutational processes in human cancer. Nature 500: 415–421.

Bellacosa A, Cicchillitti L, Schepis F, et al. (1999) MED1, a novel human methyl‐CpG‐binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proceedings of the National Academy of Sciences of the United States of America 96: 3969–3974.

Bonilla X, Parmentier L, King B, et al. (2016) Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nature Genetics 48: 398–406.

Bouaoun L, Sonkin D, Ardin M, et al. (2016) TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Human Mutation 37: 865–876.

Cao H, Jiang Y and Wang Y (2009) Kinetics of deamination and Cu(II)/H2O2/ascorbate‐induced formation of 5‐methylcytosine glycol at CpG sites in duplex DNA. Nucleic Acids Research 37: 6635–6643.

Chen J and Furano AV (2015) Breaking bad: the mutagenic effect of DNA repair. DNA Repair 32: 43–51.

Cooper DN, Mort M, Stenson PD, Ball EV and Chuzhanova NA (2010) Methylation‐mediated deamination of 5‐methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides. Human Genomics 4: 406–410.

Coulondre C, Miller JH, Farabaugh PJ and Gilbert W (1978) Molecular basis of base substitution hot spots in Escherichia coli. Nature 274: 775–780.

Denissenko MF, Pao A, Tang M and Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274: 430–432.

Denissenko MF, Chen JX, Tang MS and Pfeifer GP (1997) Cytosine methylation determines hot spots of DNA damage in the human p53 gene. Proceedings of the National Academy of Sciences of the United States of America 94: 3893–3898.

Gold B (2017) Somatic mutations in cancer: stochastic versus predictable. Mutation Research 814: 37–46.

Guza R, Ma L, Fang Q, Pegg AE and Tretyakova N (2009) Cytosine methylation effects on the repair of O6‐methylguanines within CG dinucleotides. The Journal of Biological Chemistry 284: 22601–22610.

Hainaut P, Hernandez T, Robinson A, et al. (1998) IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Research 26: 205–213.

Hainaut P and Pfeifer GP (2016) Somatic TP53 mutations in the era of genome sequencing. Cold Spring Harbor Perspectives in Medicine 6, pii: a026179. DOI: 10.1101/cshperspect.a026179.

Hardeland U, Bentele M, Jiricny J and Schar P (2003) The versatile thymine DNA‐glycosylase: a comparative characterization of the human, Drosophila and fission yeast orthologs. Nucleic Acids Research 31: 2261–2271.

He YF, Li BZ, Li Z, et al. (2011) Tet‐mediated formation of 5‐carboxylcytosine and its excision by TDG in mammalian DNA. Science 333: 1303–1307.

Ikehata H, Kawai K, Komura J, et al. (2008) UVA1 genotoxicity is mediated not by oxidative damage but by cyclobutane pyrimidine dimers in normal mouse skin. The Journal of Investigative Dermatology 128: 2289–2296.

Hendrich B, Hardeland U, Ng HH, Jiricny J and Bird A (1999) The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401: 301–304.

Lister R, Mukamel EA, Nery JR, et al. (2013) Global epigenomic reconfiguration during mammalian brain development. Science 341: 1237905.

Maiti A and Drohat AC (2011) Thymine DNA glycosylase can rapidly excise 5‐formylcytosine and 5‐carboxylcytosine: potential implications for active demethylation of CpG sites. The Journal of Biological Chemistry 286: 35334–35338.

Neddermann P, Gallinari P, Lettieri T, et al. (1996) Cloning and expression of human G/T mismatch‐specific thymine‐DNA glycosylase. Journal of Biological Chemistry 271: 12767–12774.

Pfeifer GP, Denissenko MF, Olivier M, et al. (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking‐associated cancers. Oncogene 21: 7435–7451.

Pfeifer GP (2015) How the environment shapes cancer genomes. Current Opinion in Oncology 27: 71–77.

Pleasance ED, Cheetham RK, Stephens PJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191–196.

Rideout WM III, Coetzee GA, Olumi AF and Jones PA (1990) 5‐Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249: 1288–1290.

Shen JC, Rideout WM and Jones PA (1992) High frequency mutagenesis by a DNA methyltransferase. Cell 71: 1073–1080.

Shen JC, Rideout W III and Jones PA (1994) The rate of hydrolytic deamination of 5‐methylcytosine in double‐stranded DNA. Nucleic Acids Research 22: 972–976.

Song Q, Cannistraro VJ and Taylor JS (2014) Synergistic modulation of cyclobutane pyrimidine dimer photoproduct formation and deamination at a TmCG site over a full helical DNA turn in a nucleosome core particle. Nucleic Acids Research 42: 13122–13133.

Song J and Pfeifer GP (2016) Are there specific readers of oxidized 5‐methylcytosine bases? BioEssays 38: 1038–1047.

Stenson PD, Mort M, Ball EV, et al. (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Human Genetics 133: 1–9.

Tahiliani M, Koh KP, Shen Y, et al. (2009) Conversion of 5‐methylcytosine to 5‐hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930–935.

Tommasi S, Denissenko MF and Pfeifer GP (1997) Sunlight induces pyrimidine dimers preferentially at 5‐methylcytosine bases. Cancer Research 57: 4727–4730.

Tornaletti S and Pfeifer GP (1995) Complete and tissue‐independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene 10: 1493–1499.

Tretyakova N, Guza R and Matter B (2008) Endogenous cytosine methylation and the formation of carcinogen carcinogen‐DNA adducts. Nucleic Acids Symposium Series (Oxford) 52: 49–50.

Wang HT, Weng MW, Chen WC, et al. (2013) Effect of CpG methylation at different sequence context on acrolein‐ and BPDE‐DNA binding and mutagenesis. Carcinogenesis 34: 220–227.

Weisenberger DJ and Romano LJ (1999) Cytosine methylation in a CpG sequence leads to enhanced reactivity with benzo[a]pyrene diol epoxide that correlates with a conformational change. Journal of Biological Chemistry 274: 23948–23955.

Yang AS, Gonzalgo ML, Zingg JM, et al. (1996) The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline. Journal of Molecular Biology 258: 240–250.

Yoon JH, Smith LE, Feng Z, et al. (2001) Methylated CpG dinucleotides are the preferential targets for G‐to‐T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking‐ associated lung cancers. Cancer Research 61: 7110–7117.

You YH and Pfeifer GP (2001) Similarities in sunlight‐induced mutational spectra of CpG‐methylated transgenes and the p53 gene in skin cancer point to an important role of 5‐methylcytosines in solar UV mutagenesis. Journal of Molecular Biology 305: 389–399.

Further Reading

Ehrlich M, Zhang XY and Inamdar NM (1990) Spontaneous deamination of cytosine and 5‐methylcytosine residues in DNA and replacement of 5‐methylcytosine residues with cytosine residues. Mutation Research 238: 277–286.

Hollstein M, Alexandrov LB, Wild CP, Ardin M and Zavadil J (2017) Base changes in tumour DNA have the power to reveal the causes and evolution of cancer. Oncogene 36: 158–167.

Lindahl T (1993) Instability and decay of the primary structure of DNA. Nature 362: 709–715.

Pfeifer GP, Tang M and Denissenko MF (2000) Mutation hotspots and DNA methylation. Current Topics in Microbiology and Immunology 249: 1–19.

Zuo S, Boorstein RJ and Teebor GW (1995) Oxidative damage to 5‐methylcytosine in DNA. Nucleic Acids Research 25: 3239–3243.

Web Links

Human Gene Mutation Database: http://www.hgmd.cf.ac.uk/ac/index.php

International Agency for Research on Cancer: http://www.iarc.fr/

Tumor protein p53 (TP53); LocusID: 7157. LocusLink: http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=7157

Tumor protein p53 (TP53); http://omim.org/entry/191170

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Pfeifer, Gerd P(Jun 2017) DNA Methylation and Mutation. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0006159.pub2]